Stay updated on SOUL Study: Semaglutide in Diabetes Clinical Trial
Sign up to get notified when there's something new on the SOUL Study: Semaglutide in Diabetes Clinical Trial page.

Latest updates to the SOUL Study: Semaglutide in Diabetes Clinical Trial page
- Check2 days agoChange DetectedA government funding lapse notice was added, and release notes were updated to Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.2%

- Check9 days agoChange DetectedShow glossary option is now available on the history page, and the UI now describes color-coded additions (green) and deletions (red). The revision label has been updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision history updated to include v3.3.4 and remove v3.3.3 for the study record NCT03914326. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.SummaryDifference0.0%

- Check52 days agoChange DetectedDifference0.1%

- Check74 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the Record History.SummaryDifference0.0%

Stay in the know with updates to SOUL Study: Semaglutide in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SOUL Study: Semaglutide in Diabetes Clinical Trial page.